Whole-body hyperthermia at the DGHT conference in Berlin www.hyperthermie-kongress.de Dr. Sebastian Zschaeck, from Charité University Berlin, Department of Radiooncology, reviewed the clinical data of fever-range WBH, emphasizing the need for more clinical studies, also planned at Charité University. He reported preliminary results of the ongoing study Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer. Dr. Stefan Hiller and Brigitte Deckers, from Filderklinik near Stuttgart, gave an overview of the principles of integrative oncology in an anthroposophic hospital and reported their use of fever-range whole-body hyperthermia. It is used in palliative, as well as in adjuvant settings, usually approximately 1 treatment per month. Main aims are the mitigation of side-effects of chemotherapy and the stimulation of anti-cancer immune surveillance. Dr. Kay-U. Hanusch, from Emmenspital, in Switzerland reported a systematic review of 7 studies and 148 subjects on The impact of whole-body hyperthermia interventions on mood and depression, published OPEN ACCESS in the International Journal of Hyperthermia Volume 36, 2019 - Issue 1 Print